Increasing Enoxaparin Dosing from 30 mg to 40 mg Does Not Affect Bleeding or VTE Risk in Bariatric Surgery Patients

MeSH terms

• Anticoagulants* / administration & dosage
• Anticoagulants* / adverse effects
• Bariatric Surgery*
• Dose-Response Relationship, Drug
• Enoxaparin* / administration & dosage
• Enoxaparin* / adverse effects
• Female
• Fibrinolytic Agents* / administration & dosage
• Fibrinolytic Agents* / adverse effects
• Gastric Bypass
• Hemorrhage* / chemically induced
• Humans
• Male
• Middle Aged
• Obesity* / complications
• Obesity* / surgery
• Retrospective Studies
• Risk
• Venous Thromboembolism* / etiology
• Venous Thromboembolism* / prevention & control